VICTORIA LEE MOYER
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- KOKOMO, IN
- NPI
- 1891776951
- Received
- $187,875 in 325 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 66 | $31,774 |
| 2024 | General payment | 99 | $31,993 |
| 2023 | General payment | 104 | $20,725 |
| 2022 | General payment | 18 | $27,236 |
| 2021 | General payment | 13 | $27,220 |
| 2020 | General payment | 12 | $25,920 |
| 2019 | General payment | 13 | $23,005 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $161,558 | 2020–2025 |
| Shire North American Group Inc | 11 | $22,960 | 2019 |
| Novo Nordisk Inc | 71 | $711 | 2019–2025 |
| ABBVIE INC. | 42 | $496 | 2023–2025 |
| Lilly USA, LLC | 26 | $490 | 2022–2025 |
| PFIZER INC. | 24 | $463 | 2023–2025 |
| AstraZeneca Pharmaceuticals LP | 18 | $352 | 2022–2025 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $249 | 2023–2025 |
| Dexcom, Inc. | 7 | $133 | 2022–2025 |
| Abbott Laboratories | 6 | $102 | 2024–2025 |
| Exact Sciences Corporation | 4 | $67 | 2023–2025 |
| GlaxoSmithKline, LLC. | 4 | $66 | 2023 |
| Axsome Therapeutics, Inc. | 2 | $51 | 2024–2025 |
| Amgen Inc. | 3 | $47 | 2024–2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 | 2019 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 | 2025 |
| Lundbeck LLC | 1 | $17 | 2024 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 | 2025 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 | 2025 |
| Inspire Medical Systems, Inc. | 1 | $14 | 2025 |
| Astellas Pharma US Inc | 1 | $12 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 86 | $184,310 |
| Food and Beverage | 238 | $3,492 |
| Travel and Lodging | 1 | $72 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | Takeda Pharmaceuticals U.S.A., Inc. | $2,460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | Exact Sciences Corporation | $14 | Food and Beverage | In-kind items and services | The Cologuard Plus Collection Kit Device, Oncology | 2025 | |
| 2025-11-20 | Takeda Pharmaceuticals U.S.A., Inc. | $7 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-11-12 | Takeda Pharmaceuticals U.S.A., Inc. | $2,460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-06 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-24 | Takeda Pharmaceuticals U.S.A., Inc. | $1,230 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | Takeda Pharmaceuticals U.S.A., Inc. | $72 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-10-14 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-10-08 | Takeda Pharmaceuticals U.S.A., Inc. | $2,460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-30 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-09-30 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-23 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-22 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-09-22 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-09-15 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-09-10 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-02 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | PREVNAR 20 Biological, VACCINES | 2025 | |
| 2025-08-20 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-08-20 | Takeda Pharmaceuticals U.S.A., Inc. | $4 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-08-19 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-19 | Novo Nordisk Inc | $4 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-19 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-08 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-08-05 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-29 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-07-23 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2025 | |
| 2025-07-22 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-07-18 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-15 | Dexcom, Inc. | $21 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-07-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-06-17 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-06-10 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-06-06 | Takeda Pharmaceuticals U.S.A., Inc. | $1,180 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-29 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-05-20 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-05-14 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-05-09 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-01 | Novo Nordisk Inc | $8 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-04-29 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-04-22 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-04-15 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-09 | Phathom Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-08 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-04-01 | Axsome Therapeutics, Inc. | $27 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-25 | Inspire Medical Systems, Inc. | $14 | Food and Beverage | In-kind items and services | INSPIRE Device, NEUROLOGY | 2025 | |
| 2025-03-18 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-03-12 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-26 | Abbott Laboratories | $14 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-02-26 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-02-25 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-02-18 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-02-12 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-11 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-02-04 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-01-28 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-01-22 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2025 | |
| 2025-01-21 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-14 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2025 | |
| 2025-01-09 | Phathom Pharmaceuticals, Inc. | $7 | Food and Beverage | Cash or cash equivalent | VOQUEZNA Drug, Gastroenterology | 2025 | |
| 2024-12-12 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-12-10 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-03 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-12-03 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-11-14 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-11-13 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-13 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-11-07 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-11-05 | Abbott Laboratories | $13 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-10-29 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-15 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-10-08 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | ABRYSVO Biological, VACCINES | 2024 | |
| 2024-09-17 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-09-13 | Takeda Pharmaceuticals U.S.A., Inc. | $590 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-09-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-09-11 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-09-09 | Lilly USA, LLC | $22 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-09-04 | Bayer Healthcare Pharmaceuticals Inc. | $30 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-08-23 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-08-23 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-08-21 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-08-13 | Takeda Pharmaceuticals U.S.A., Inc. | $15 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-08-07 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-07-26 | Takeda Pharmaceuticals U.S.A., Inc. | $1,180 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-07-23 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-07-22 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-19 | Abbott Laboratories | $18 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-07-18 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-07-16 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-07-16 | Novo Nordisk Inc | $2 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-07-09 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-07-02 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-06-25 | Exact Sciences Corporation | $17 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-06-18 | Lilly USA, LLC | $10 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-11 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-06-10 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-06-10 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-06-05 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-06-04 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-05-29 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-05-22 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-05-17 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-05-15 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-05-10 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-05-08 | Takeda Pharmaceuticals U.S.A., Inc. | $590 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-05-08 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-05-06 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-05-06 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-04-30 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-25 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-04-23 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-04-22 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-19 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-04-18 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-04-18 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-04-18 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-04-18 | Novo Nordisk Inc | $4 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-04-17 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-04-12 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-04-10 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-04-10 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-09 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-09 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-03 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-04-02 | Bayer Healthcare Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-04-02 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-03-28 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-03-20 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-03-20 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-03-18 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-12 | Abbott Laboratories | $22 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-03-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-03-07 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-03-05 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2024 | |
| 2024-03-04 | Dexcom, Inc. | $23 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-02-29 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | PREVNAR 20 Biological, VACCINES | 2024 | |
| 2024-02-27 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-02-26 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2024-02-21 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-02-20 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-02-15 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-02-15 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-02-14 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-02-13 | Lilly USA, LLC | $8 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-02-12 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-08 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-02-07 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-02-05 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-01-31 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | PAXLOVID Drug, INFECTIOUS DISEASES | 2024 | |
| 2024-01-30 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-01-23 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-01-22 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-01-17 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-01-10 | AstraZeneca Pharmaceuticals LP | $55 | Food and Beverage (11 payments) | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-01-09 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-08 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2024 | |
| 2023-12-15 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-12-14 | Novo Nordisk Inc | $5 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-12-12 | Bayer Healthcare Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-12-12 | Bayer Healthcare Pharmaceuticals Inc. | $4 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-12-11 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-12-05 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-12-04 | Astellas Pharma US Inc | $12 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-11-27 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-11-22 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | PREVNAR 20 Biological, VACCINES | 2023 | |
| 2023-11-20 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-11-13 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-11-13 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2023 | |
| 2023-11-10 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-11-08 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-11-08 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-11-07 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-11-06 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2023 | |
| 2023-10-31 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-10-25 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-24 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-10-24 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-10-16 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-10-10 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $2,360 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2023 | |
| 2023-10-04 | Bayer Healthcare Pharmaceuticals Inc. | $3 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-10-03 | Bayer Healthcare Pharmaceuticals Inc. | $33 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2023 | |
| 2023-10-03 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-10-03 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-10-02 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2023 | |
| 2023-09-27 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-09-27 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-09-25 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2023 | |
| 2023-09-21 | Novo Nordisk Inc | $3 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2023 | |
| 2023-09-19 | GlaxoSmithKline, LLC. | $21 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2023 |
The latest 200 records of 325.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Kokomo, IN, county Howard County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Kokomo, IN | County Howard County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 59,122 | 83,752 | 6,851,073 |
| Population, 2020 census P1 | 59,604 | 83,658 | 6,785,528 |
| Median age B01002 | 39.4 | 40.7 | 38.1 |
| Under 18 B01001 | 23.3% | 22.8% | 23.3% |
| 65 and over B01001 | 19.2% | 19.9% | 16.8% |
| Households B11001 | 26,241 | 35,593 | 2,716,009 |
| Foreign born B05002 | 2.5% | 1.9% | 6.3% |
| Median household income B19013 | $55,360 | $64,027 | $71,957 |
| Median family income B19113 | $74,956 | $84,811 | $90,767 |
| Per capita income B19301 | $32,594 | $35,963 | $38,351 |
| Poverty rate B17001 | 17.1% | 13.4% | 12.3% |
| Unemployment rate B23025 | 6.2% | 5.8% | 4.3% |
| Civilian labor force B23025 | 26,827 | 39,175 | 3,472,016 |
| Mean commute (minutes) B08013 | 19.1 | 20.4 | 24.1 |
| Bachelor's degree or higher B15003 | 18.1% | 20.8% | 29.5% |
| Housing units B25001 | 29,814 | 39,876 | 2,976,568 |
| Owner-occupied B25003 | 63.0% | 70.6% | 70.6% |
| Renters B25003 | 37.0% | 29.4% | 29.4% |
| Median home value B25077 | $137,400 | $165,000 | $218,200 |
| Median gross rent B25064 | $939 | $937 | $1,062 |
| White, not Hispanic B03002 | 78.8% | 82.6% | 75.4% |
| Black B03002 | 9.9% | 7.3% | 9.1% |
| Hispanic or Latino B03002 | 4.3% | 4.1% | 8.6% |
| Asian B03002 | 2.0% | 1.4% | 2.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Kokomo, IN.
Comments